Statins
Sort by:
Cleveland Clinic Heart, Vascular and Thoracic Institute
Heart Outcomes Prevention Evaluation–3 - HOPE-3 Trial
FEATURING
Steven Nissen
- 1,771 views
- July 26, 2016
- 13
The North American Thrombosis Forum (NATF)
Clot Chronicles: Peripheral Artery Disease — What Clinicians Should Know
FEATURING
Mary Mcdermott
- 304 views
- January 13, 2022
- 4
McMaster University Department of Medicine
Familial Hypercholesterolemia: What You Need to Know
FEATURING
Robert Hegele
- 813 views
- June 14, 2024
- 8
The Texas Heart Institute
The Use of Coronary Artery Calcium Score to Determine Benefit of Aspirin Therapy
FEATURING
Eduardo Hernandez
- 1,144 views
- November 12, 2021
- 11
National Lipid Association
Pearls from 34 Years of Running a Lipid Clinic
FEATURING
Alan Brown
- 1,161 views
- March 25, 2019
- 11
Georgia Heart Institute
Revascularization vs. Medical Therapy for Stable Ischemic Heart Disease – a Post-Lecture Interview
FEATURING
Spencer III,
William Boden
- 76 views
- August 14, 2024
- 1
ASPC 2019 Congress on CVD Prevention
REDUCE-IT and Treating Beyond LDL-C Lowering
FEATURING
Deepak Bhatt
- 771 views
- August 9, 2019
- 8
Canadian Collaborative Research Network
Has the Time Come to Treat Inflammation to Improve Cardiovascular Outcomes? (Yes!)
FEATURING
Paul Ridker
- 1,408 views
- July 26, 2023
- 10
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Defining and Treating Dyslipidemia
FEATURING
Michael J. Wilkinson
- 1,446 views
- March 6, 2024
- 11
Cleveland Clinic | 12th Annual Obesity Summit
Management of Hypertension and Hyperlipidemia in Type 2 Diabetes
FEATURING
Steven Nissen
- 2,155 views
- December 3, 2017
- 8
Penn Medicine Heart and Vascular Center
Lipoprotein(a) and Cardiovascular Risks: New Insights
FEATURING
Vera Bittner
- 2,059 views
- December 19, 2023
- 10
MUSC Cardiology
Evolving Therapies in Dyslipidemia, ASCVD Risk Reduction: Putting It All Together in High-Risk Patients
FEATURING
Pamela B. Morris
- 838 views
- March 29, 2024
- 8
University of Colorado Department of Medicine
Beyond LDL: Assessing and Treating Residual ASCVD Risk
FEATURING
Marc-Andre Cornier
- 705 views
- October 6, 2021
- 7
Scripps Health
Master Class on LDL-C, LP(a), and Non-HDL: How Low to Go?
FEATURING
Douglas Triffon
- 1,413 views
- July 3, 2024
- 10
Houston Methodist DeBakey Heart and Vascular Center
Update on Inflammation & Atherosclerosis Treatment: Should All Atherosclerosis Patients Receive Aggressive Lipid-Lowering and Inflammation Inhibiting Therapy? Why Not Combine Anti-Inflammatory Therapy with PCSK9 Inhibition?
FEATURING
Paul Ridker
- 1,523 views
- July 14, 2020
- 9
Cardiology Pulse 2019
Top 5 Cardiovascular Prevention Trials
FEATURING
Robert Chilton
- 267 views
- October 30, 2019
- 3
Penn Medicine Heart and Vascular Center
What Are the Metabolic Consequences of Insulin Resistance and What Is the Optimal LDL in These Patients?
FEATURING
Daniel Soffer
- 617 views
- November 21, 2023
- 6
KDIGO
Primary Care in Chronic Kidney Disease: Insights from the KDIGO 2024 CKD Guideline
FEATURING
Michael Shlipak
- 625 views
- April 8, 2024
- 6
